11/8
01:50 pm
crmd
CorMedix (CRMD) Upgraded to Strong Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Low
Report
CorMedix (CRMD) Upgraded to Strong Buy: What Does It Mean for the Stock? [Yahoo! Finance]
11/4
08:30 am
crmd
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
Medium
Report
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
11/4
05:50 am
crmd
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic [Yahoo! Finance]
Medium
Report
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic [Yahoo! Finance]
11/2
05:02 am
crmd
CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at StockNews.com to a "sell" rating.
11/1
08:40 am
crmd
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate [Yahoo! Finance]
Low
Report
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate [Yahoo! Finance]
10/31
08:35 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its price target raised by analysts at Needham & Company LLC from $10.00 to $18.00. They now have a "buy" rating on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) had its price target raised by analysts at Needham & Company LLC from $10.00 to $18.00. They now have a "buy" rating on the stock.
10/30
07:30 am
crmd
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
High
Report
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
10/24
08:30 am
crmd
CorMedix Inc. Announces New Data at ASN Kidney Week 2024
Low
Report
CorMedix Inc. Announces New Data at ASN Kidney Week 2024
10/23
08:30 am
crmd
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024
Medium
Report
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024
10/22
05:56 pm
crmd
CorMedix Inc. (CRMD): A Bull Case Theory [Yahoo! Finance]
Medium
Report
CorMedix Inc. (CRMD): A Bull Case Theory [Yahoo! Finance]
10/22
01:39 pm
crmd
CorMedix Inc. (NASDAQ: CRMD) had its price target raised by analysts at Truist Financial Co. from $12.00 to $17.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its price target raised by analysts at Truist Financial Co. from $12.00 to $17.00. They now have a "buy" rating on the stock.
10/19
05:31 am
crmd
CorMedix: Delayed Approval, Low Cash, Good Prospects [Seeking Alpha]
Low
Report
CorMedix: Delayed Approval, Low Cash, Good Prospects [Seeking Alpha]
10/8
08:00 am
crmd
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator
Medium
Report
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator
9/25
07:37 am
crmd
CorMedix Inc. (NASDAQ:CRMD): When Will It Breakeven? [Yahoo! Finance]
Medium
Report
CorMedix Inc. (NASDAQ:CRMD): When Will It Breakeven? [Yahoo! Finance]
9/19
08:00 am
crmd
CorMedix Inc. Announces New Commercial Agreement
Medium
Report
CorMedix Inc. Announces New Commercial Agreement
9/13
08:30 am
crmd
CorMedix Inc. to Present at the Cantor Global Healthcare Conference
Medium
Report
CorMedix Inc. to Present at the Cantor Global Healthcare Conference
9/9
11:59 am
crmd
Here's Why CorMedix (CRMD) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]
Medium
Report
Here's Why CorMedix (CRMD) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]
9/9
11:37 am
crmd
CorMedix announces new commercial agreement [Seeking Alpha]
Medium
Report
CorMedix announces new commercial agreement [Seeking Alpha]
9/9
10:52 am
crmd
CorMedix Inc. Announces New Commercial Agreement
Low
Report
CorMedix Inc. Announces New Commercial Agreement
9/5
01:55 pm
crmd
CorMedix (CRMD) Is Up 10.44% in One Week: What You Should Know [Yahoo! Finance]
Low
Report
CorMedix (CRMD) Is Up 10.44% in One Week: What You Should Know [Yahoo! Finance]
8/26
08:03 am
crmd
CorMedix Inc. (NASDAQ: CRMD) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $13.00 price target on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $13.00 price target on the stock.